A nurse is assessing a 32-year-old gravida 3, para 2 client at 10 weeks gestation who presents with vaginal bleeding and severe nausea and vomiting. Which assessment finding would be most characteristic of a hydatidiform mole?

This question tests your ability to recognize the classic clinical presentation of a hydatidiform mole (molar pregnancy), a form of gestational trophoblastic disease (GTD). The client's presentation of first-trimester vaginal bleeding accompanied by severe nausea and vomiting (hyperemesis) should immediately raise your index of suspicion for a molar pregnancy. The severe nausea is linked to markedly elevated levels of beta-human chorionic gonadotropin (β-hCG), which is a hallmark of this condition.

In a complete hydatidiform mole (CHM), there is abnormal, rapid proliferation of trophoblastic tissue. This excessive tissue growth causes the uterus to enlarge at a rate faster than expected for the gestational age. Therefore, a fundal height measurement that is larger than expected for dates is a highly characteristic assessment finding. This is a key point of differentiation from a threatened or spontaneous abortion, where the fundal height is typically equal to or smaller than expected for gestational age. The provided literature confirms that uterine enlargement is a typical clinical presentation of CHM, driven by the abnormal trophoblastic proliferation and significantly elevated β-hCG levels ^[3].

To understand why the uterus is larger, follow the underlying mechanism. In a complete mole, an "empty" egg (devoid of maternal DNA) is fertilized, leading to a paternal-only genetic makeup. This triggers unchecked growth of the cytotrophoblast and syncytiotrophoblast layers. The chorionic villi become edematous and distended, forming grape-like vesicles that fill the uterine cavity more rapidly than a normal fetus and amniotic sac would. This rapid tissue expansion, rather than fetal growth, is what causes the fundal height to exceed the expected measurement for the 10-week gestation date. The excessive β-hCG produced by the hyperplastic trophoblast directly stimulates the chemoreceptor trigger zone, explaining the severe nausea and vomiting ^[3].

• Option 1 (Fundal height equal to expected): This finding is typical of a normal intrauterine pregnancy or a missed abortion. It is not characteristic of a rapidly proliferating molar pregnancy.


• Option 2 (Fundal height measuring larger than expected): This is the correct answer. The excessive growth of trophoblastic tissue causes the uterus to be larger than dates, a classic sign of a hydatidiform mole ^[3].


• Option 3 (Fundal height smaller than expected): This finding might suggest an error in dating, a fetal growth restriction, or an intrauterine fetal demise. It is inconsistent with the pathophysiology of a complete mole.


• Option 4 (Fundal height not assessed due to bleeding): While caution is always used, vaginal bleeding is not a contraindication for a gentle abdominal assessment of fundal height. This assessment provides critical diagnostic information and should not be omitted solely because bleeding is present.

From an NCLEX-RN safety perspective, recognizing a fundal height greater than dates in a patient with first-trimester bleeding and hyperemesis is a critical clinical judgment. It directs the nurse to prioritize notifying the healthcare provider for immediate diagnostic evaluation, including a quantitative β-hCG level and pelvic ultrasound. The β-hCG level in a molar pregnancy is often dramatically elevated, well above the normal range for the gestational age ^[3]. A delay in diagnosis can lead to serious complications, including hemorrhage, preeclampsia before 20 weeks, and the rare but serious progression to invasive mole or choriocarcinoma . The nurse's accurate physical assessment is the first step in triggering this essential diagnostic cascade.